Production & Sales

12 Jan 2021
- Production & Sales
- Manufacturing
Rocket Pharmaceuticals announces buildout of R&D and manufacturing facility to support development of gene therapy pipeline

By PBR Staff Writer

Rocket Pharmaceuticals, a clinical-stage company advancing an integrated and sustainable pipeline of genetic therapies for rare childhood disorders, today announces the Company’s plans for the buildout of its new Research and Development (R&D) and Chemistry, Manufacturing and Controls (CMC) operation which will also serve as the Company’s new headquarters in Cranbury, New Jersey.
06 Jan 2021
Production & Sales
Manufacturing
LakePharma to manufacture Akston Biosciences’ Covid-19 vaccine

By PBR Staff Writer

Akston Biosciences has entered into a strategic partnership with US-based contract research, development, and manufacturing organisation (CRDMO) LakePharma to manufacture second-generation Covid-19 vaccine.
24 Dec 2020
Production & Sales
Marketing & Sales
Merck announces supply agreement with US for initial doses of investigational biological therapy to treat Covid-19

By PBR Staff Writer

Merck, known as MSD outside the United States and Canada, announced it has entered into an agreement with the United States Government to support the development, manufacture and initial distribution of an investigational biological therapeutic (CD24Fc, to be named MK-7110) upon approval or Emergency Use Authorization (EUA) from the U.S. Food and Drug Administration (FDA).
24 Dec 2020
Production & Sales
Marketing & Sales
Pfizer, BioNTech agree to supply additional 100 million Covid-19 vaccine doses to US

By PBR Staff Writer

Pfizer and BioNTech have entered into a second agreement with the US government to supply an additional 100 million doses of their Covid-19 vaccine.
21 Dec 2020
Production & Sales
Manufacturing
EIB launches €50m Africa pharmaceutical manufacturing initiative

By PBR Staff Writer

The European Investment Bank launched the first ever scheme to strengthen local production of Active Pharmaceutical Ingredients in Africa and scale up drug manufacturing essential to improve public health.
15 Dec 2020
Production & Sales
Marketing & Sales
Moderna confirms agreement with Singapore for supply of mRNA vaccine against Covid-19

By PBR Staff Writer

Moderna confirmed that the Company concluded an agreement with the Ministry of Health of Singapore to supply mRNA-1273, Moderna’s vaccine candidate against COVID-19, to support ongoing efforts to secure access to a safe and effective COVID-19 vaccine for the people of Singapore.
10 Dec 2020
Production & Sales
Manufacturing
Thermo Fisher Scientific further expands global footprint for drug product development and commercial manufacturing

By PBR Staff Writer

Thermo Fisher Scientific, the world leader in serving science, announced it will further expand its footprint in North America and Europe for sterile drug product development and commercial manufacturing of critical medicines, therapies and vaccines.
09 Dec 2020
Production & Sales
Manufacturing
BioCryst announces $325m of funding from Royalty Pharma and Athyrium Capital Management

By PBR Staff Writer

BioCryst Pharmaceuticals, Royalty Pharma, and Athyrium Capital Management, announced transactions totaling $325 million in funding for BioCryst, with $250 million available at closing, to support the launch of ORLADEYO (berotralstat) in hereditary angioedema (HAE) and the development of its oral Factor D inhibitor, BCX9930.
09 Dec 2020
Production & Sales
Manufacturing
Piramal Pharma Solutions invests $32m to expand Riverview Michigan facility

By PBR Staff Writer

Piramal Pharma Limited's Pharma Solutions business, a leading Contract Development and Manufacturing Organization (CDMO) announced plans to expand its facility in Michigan with additional capacity and new capabilities for the development and manufacturing of Active Pharmaceutical Ingredients (APIs).
03 Dec 2020
Production & Sales
Marketing & Sales
Eli Lilly announces 650,000 additional doses of bamlanivimab purchased by US government to treat Covid-19

By PBR Staff Writer

The US government has purchased 650,000 additional doses of Eli Lilly and Company's (NYSE: LLY) neutralizing antibody bamlanivimab (LY-CoV555) 700 mg. The purchase agreement is for $812.5 million and the doses will be delivered through January 31, 2021, with at least 350,000 of the additional doses delivered in December 2020.

Drug Discovery

Research & Development

Rallybio to acquire Candid Therapeutics

Kairos Pharma signs deal for Celyn Therapeutics’ CL-273

Clinical Trials

Patient Enrollment

US FDA approves Avacta Group’s IND application for AVA6000

AM-Pharma enrols first patients in Covid-19 phase III trial

Regulation

Drug Filing

Viatris files applications in Japan for approval of Effexor to treat GAD

Scholar Rock submits application of SMA therapy to FDA

Production & Sales

Manufacturing

ENCell and Lucy Biotech forge alliance for mesenchymal stem cell therapy

Merck introduces single-use reactor to accelerate ADC manufacturing

Packaging & Supply Chain

Packaging

Gerresheimer at CPHI Frankfurt 2025

Gerresheimer

Suppliers

No data found

Production & Sales

Rocket Pharmaceuticals announces buildout of R&D and manufacturing facility to support development of gene therapy pipeline

LakePharma to manufacture Akston Biosciences’ Covid-19 vaccine

Merck announces supply agreement with US for initial doses of investigational biological therapy to treat Covid-19

Pfizer, BioNTech agree to supply additional 100 million Covid-19 vaccine doses to US

EIB launches €50m Africa pharmaceutical manufacturing initiative

Moderna confirms agreement with Singapore for supply of mRNA vaccine against Covid-19

Thermo Fisher Scientific further expands global footprint for drug product development and commercial manufacturing

BioCryst announces $325m of funding from Royalty Pharma and Athyrium Capital Management

Piramal Pharma Solutions invests $32m to expand Riverview Michigan facility

Eli Lilly announces 650,000 additional doses of bamlanivimab purchased by US government to treat Covid-19

Pharmaceutical Business review is using cookies

Research & Development

Patient Enrollment

Drug Filing

Manufacturing

Packaging

No data found